These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

827 related items for PubMed ID: 6233359

  • 1. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO, Ealding W.
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-H gamma 1 transgenic mice.
    Gärdby E, Lane P, Lycke NY.
    J Immunol; 1998 Jul 01; 161(1):49-59. PubMed ID: 9647206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
    Bromander AK, Ekman L, Kopf M, Nedrud JG, Lycke NY.
    J Immunol; 1996 Jun 01; 156(11):4290-7. PubMed ID: 8666800
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impaired B cell responses to orally administered antigens in lamina propria but not Peyer's patches of Galphai2-deficient mice prior to colitis.
    Ohman L, Aström RG, Hultgren Hörnquist E.
    Immunology; 2005 Jun 01; 115(2):271-8. PubMed ID: 15885134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. IgA responses in xid mice: oral antigen primes Peyer's patch cells for in vitro immune responses and secretory antibody production.
    Kiyono H, Mosteller LM, Eldridge JH, Michalek SM, McGhee JR.
    J Immunol; 1983 Dec 01; 131(6):2616-22. PubMed ID: 6227659
    [Abstract] [Full Text] [Related]

  • 14. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
    Chen KS, Strober W.
    Eur J Immunol; 1990 Feb 01; 20(2):433-6. PubMed ID: 2311649
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
    Tomasi M, Dertzbaugh MT, Hearn T, Hunter RL, Elson CO.
    Eur J Immunol; 1997 Oct 01; 27(10):2720-5. PubMed ID: 9368632
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding.
    Richman LK, Graeff AS, Yarchoan R, Strober W.
    J Immunol; 1981 Jun 01; 126(6):2079-83. PubMed ID: 6164719
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
    Jackson RJ, Fujihashi K, Xu-Amano J, Kiyono H, Elson CO, McGhee JR.
    Infect Immun; 1993 Oct 01; 61(10):4272-9. PubMed ID: 8406816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.